An observational study of nab-paclitaxel-induced peripheral neuropathy
Not Applicable
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000020852
- Lead Sponsor
- Osaka Police Hospital
- Brief Summary
Patient-reported nPIPN was significantly getting worse without frozen gloves during chemotherapy, however be largely reversible within 1 year of PST or adjuvant treatment. The J-Q findings support that nab-PTX treatment is tolerable.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 105
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Physician concludes that the patient's participation in this trial is inappropriate
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method